Diet-gene interactions in p53-deficient mice: Insulin-like growth factor-1 as a mechanistic target

Journal of Nutrition

Volumn 134, Issue 9, 2004, Pages

  Hursting, Stephen D ^a   Lavigne, Jackie A ^a   Berrigan, David ^a   Donehower, Lawrence A ^b   Davis, Barbara J ^c   Phang, James M ^a   Barrett, J Carl ^a   Perkins, Susan N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Calorie restriction; Chemoprevention; Insulin like growth factor 1; Leptin; Nutrition; Transgenics

Indexed keywords

AMINE; LEPTIN; PROTEIN P53; SOMATOMEDIN C;

APOPTOSIS; BLADDER CARCINOGENESIS; CALORIC RESTRICTION; CANCER GENETICS; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONFERENCE PAPER; DIET; DNA MICROARRAY; ENERGY BALANCE; EPITHELIUM TUMOR; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; LYMPHOMA; MOUSE; NONHUMAN; OBESITY; RUNNING; SARCOMA; THYMOCYTE; TREADMILL; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 4444336982     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.9.2482s     Document Type: Conference Paper

References (61)

1. Hursting, S. D., Slaga, T. J., Fischer, S. M., DiGiovanni, J. & Phang, J. M. (1999) Mechanism-based cancer prevention approaches: Targets, examples and the use of transgenic mice. J. Natl. Cancer Inst. 91: 215-225.
2. vonEschenbach, A. C. (2003) NCI sets goal of eliminating suffering and death due to cancer by 2015. J. Natl. Med. Assoc. 95: 637-639.
3. Flegal, K. M., Carroll, M. D., Ogden, C. L. & Johnson, C. L. (2002) Prevalence and trends in obesity among US adults, 1999-2000. J. Am. Med. Assoc. 288: 1723-1727.
4. Hill, J. O., Wyatt, H. R., Reed, G. W. & Peters, J. C. (2003) Obesity and the environment: Where do we go from here? Science 299: 853-855.
5. Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. (2003) Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348: 1625-1638.
6. Walsberg, G. E. (2003) How useful is energy balance as an overall index of stress in animals. Horm. Behav. 43: 16-17.
7. Hursting, S. D., Lavigne, J. A., Berrigan, D. A., Perkins, S. N. & Barrett, J. C. (2003) Calorie restriction, aging and cancer prevention: Mechanisms of action and applicability to humans. Ann. Rev. Med. 54: 131-152.
8. Hursting, S. D., Perkins, S. N., Brown, C. C., Haines, D. C. & Phang, J. M. (1997) Calorie restriction induces a p53-independent delay of spontaneous carcinogenesis in p53-deficient and wild-type mice. Cancer Res. 57: 2843-2846.
9. Lin, S. J., Kaeberlein, M., Andalis, A. A., Sturtz, L. A., Defossez, P. A., Culotta, V. C., Fink, G. R. & Guarente, L. (2002) Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature 418: 344-348.
10. Johnson, P. R., Stem, J. S., Horwitz, B. A., Harris, R. E., Jr. & Greene, S. F. (1997) Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia. Am. J. Clin. Nutr. 66: 890-903.
11. Austad, S. N. (1989) Life extension by dietary restriction in the bowl and doily spider, Frontinella pyramitela. Exp. Gerontol. 24(1): 83-92.
12. Lakowski, B. & Hekimi, S. (1998) The genetics of caloric restriction in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 95: 13091-13096.
13. Clancy, D. J., Gems, D., Hafen, E., Leevers, S. J. & Partridge, L. (2002) Dietary restriction in long-lived dwarf flies. Science 296: 319-325.
14. Harrison, D. E., Archer, J. R. & Astle, C. M. (1984) Effects of food restriction on aging: separation of food intake and adiposity. Proc. Natl. Acad. Sci. U.S.A. 81: 1835-1838.
15. Weindruch, R., Walford, R. L., Fligiel, S. & Guthrie, D. (1986) The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J. Nutr. 116: 641-654.
16. Yu, B. P., Masoro, E. J., Murata, I., Bertrand, H. A. & Lynd, F. T. (1982) Life span study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass and disease. J. Gerontol. 37: 130-141.
17. Kealy, R. D., Lawler, D. E., Ballam, J. M., Mantz, S. L., Biery, D. N., Greeley, E. H., Lust, G., Segre, M., Smith, G. K. & Stowe, H. D. (2002) Effects of diet restriction on life span and age-related changes in dogs. J. Am. Vet. Med. Assoc. 220: 1315-1320.
18. Pinney, D. O., Stephens, D. F. & Pope, L. S. (1972) Lifetime effects of winter supplemental feed level and age at first parturition on range beef cows. J. Animal Sci. 34: 1067-1074.
19. Hursting, S. D. & Kari, F. W. (1999) The anti-carcinogenic effects of dietary restriction: Mechanisms and future directions. Mut. Res. 443: 235-249.
20. Hursting, S. D. & Lubet, R. A. (2001) The utility of transgenic mice in cancer prevention studies. In: Tumor Models in Cancer Research (Teicher, B., ed.), pp 263-274. Humana Press, Inc., Totowa, NJ.
21. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. (1991) p53 mutations in human cancers. Science 253: 49-53.
22. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. & Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (London) 356: 215-221.
23. Kemp, C. J., Donehower, L. A., Bradley, A. & Balmain, A. (1993) Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74: 813-822.
24. Hursting, S. D., Perkins, S. N. & Phang, J. M. (1994) Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 91: 7036-7040.
25. Hursting, S. D., Perkins, S. N., Ward, J., Haines, D. & Phang, J. M. (1995) Chemoprevention of spontaneous tumorigenesis in p53-knockout mice. Cancer Res. 55: 3949-3953.
26. Perkins, S. N., Hursting, S. D., Haines, D. C., James, S. J. & Phang, J. M. (1997) Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog, 16-α-fluoro-5-androsten-17-one. Carcinogenesis 18: 101-106.
27. Schwartz, A. G. & Pashko, L. L. (1995) Mechanism of cancer preventive action of DHEA. Role of glucose 6-phosphate dehydrogenase. Ann. N.Y. Acad. Sci. 774: 180-186.
28. Wang, T.T.Y., Hursting, S. D., Perkins, S. N. & Phang, J. M. (1997) Effects of dehydroepiandrosterone and calorie restriction on the Bcl-2/Bax-mediated apoptotic pathway in p53-deficient mice. Cancer Letts. 116: 61-69.
29. Poetschke, H. L., Klug, D. B., Perkins, S. N., Wang, T.T.Y., Richie, E. R. & Hursting, S. D. (2000) The effects of calorie restriction on thymocyte growth, death and maturation. Carcinogenesis 21: 1959-1964.
30. Berrigan, D. A., Perkins, S. N., Haines, D. C. & Hursting, S. D. (2002) Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23: 817-822.
31. Dunn, S. E., Kari, F. W., French, J. E., Leininger, J. R., Travlos, G., Wilson, R. & Barrett, J. C. (1997) Dietary restriction reduces insulin-like growth factor- 1 levels which modulates apoptosis, cell proliferation, and tumor progression in p53 deficient mice. Cancer Res. 57: 4667-4672.
32. Loffreda, S., Yang, S. Q., Lin, H. Z., Karp, C. L., Brengman, M. L. & Wang, D. J. (1998) Leptin regulates proinflammatory immune responses. FASEB J. 12: 57-65.
33. Sierra-Honigmann, M. R., Nath, A. K., Murakami, M., Garcia-Cardeña, G., Papapetropoulos, A., Sessa, W. C., Madge, L. A., Schechner, J. S., Schwabb, M. B., Polverini, P. J. & Flores-Riveros, J. R. (1998) Biologic action of leptin as an angiogenic factor. Science 281: 1683-1686.
34. Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R. & Lechler, R. I. (1998) Leptin modulates the T-cell immune response and reverses starvation- induced immunosuppression. Nature 394: 897-901.
35. Mei, J. M., Hursting, S. D., Perkins, S. N. & Phang, J. M. (1998) p53-independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages. Cancer Letts. 129: 191-197.
36. Vealey, J. M. (2003) Germline TP53 mutation and Li-Fraumeni syndrome. Hum. Mutat. 21: 313-320.
37. Harvey, M., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., Bradley, A. & Donehower, L. A. (1993) Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Gen. 4: 225-229.
38. Kupperwasser, C., Hudbut, G. D., Kittrell, E. S., Laucirica, R., Medina, D., Naber, S. P. & Jerry, D. J. (2000) Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice: A model for Li-Fraumeni syndrome. Am. J. Pathol. 157: 151-159.
39. Kemp, C. J., Wheldon, T. & Balmain, A. (1994) p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Gen. 8: 66-69.
40. Hursting, S. D., Switzer, B. R., French, J. E. & Kari, F. W. (1993) The growth hormone: insulin-like growth factor 1 axis is a mediator of diet restriction-induced inhibition of mononuclear cell leukemia in Fischer rats. Cancer Res. 53: 2750-2757.
41. Macaulay, V. M. (1992) Insulin-like growth factors and cancer. Br. J. Cancer 65: 311-320.
42. LeRoith, D., Baserga, R., Helman, L. & Roberts, C. T., Jr. (1999) Insulin-like growth factors and cancer. Ann. Intern. Med. 122: 54-59.
43. Singh, P., Dai, B., Yallampalli, U., Lu, X. & Schroy, P. C. (1996) Proliferation and differentiation of a human colon cancer cell line (CaCo2) Is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein-4: Role of IGF-II. Endocrinol. 137: 1764-1774.
44. Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R. & Kley, N. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649.
45. Takahashi, K. & Suzuki, K. (1993) Association of insulin-like growth-factor I-induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells. Int. J. Cancer 55: 453-458.
46. Flurkey, K., Papaconstantinou, J., Miller, R. A. & Harrison, D. E. (2001) Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl. Acad. Sci. U.S.A. 98: 6736-6741.
47. Coschigano, K. T., Clemmons, D., Bellush, L. L. & Kopchick, J. J. (2000) Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinol. 141: 2608-2613.
48. dw can increase life span in mice. Mech. Ageing Dev. 123: 121-130.
49. Brown-Borg, H. M., Borg, K. E., Meliska, C. J. & Bartke, A. (1996) Dwarf mice and the ageing process. Nature 384: 33-36.
50. DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltran, L., Moats, S., Ramirez, A., Jorcano, J. & Conti, C. (2000) Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 97: 3455-3460.
51. Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E. & Pollak, M. (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351: 1393-1396.
52. Yu, H., Jin, F., Shu, X. O., Li, B. D., Dai, Q., Cheng, J. R., Berkel, H. J. & Zheng, W. (2002) Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol. Biomarkers Prev. 11: 705-712.
53. Kaaks, R., Lundin, E., Rinaldi, S., Manjer, J., Biessy, C., Soderberg, S., Lenner, P., Janzon, L., Riboli, E., Bergland, G. & Hallmans, G. (2002) Prospective study of IGF-1, IGF-binding proteins and breast cancer risk in northern and southern Sweden. Cancer Causes Control 13: 307-316.
54. Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H. & Pollak, M. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566.
55. Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K. & Wu, X. (1999) Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J. Natl. Cancer Inst. 91: 151-156.
56. Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H. & Stampfer, M. J. (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. 91: 620-625.
57. Zhao, H., Grossman, H. B., Spitz, M. R., Lerner, S. P., Zhang, X. & Wu, X. (2003) Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J. Urol. 169: 714-717.
58. Petridou, E., Dessypris, N., Spanos, E., Mantzoros, C., Skalkidou, A., Kalmanti, M., Koliouskas, D., Kosmidis, H., Pangiotou, F., Tzartzatou, F. & Trichopoulos, D. (1999) Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia. Int. J. Cancer 80: 494-496.
59. Jones, J. M., Attardi, L., Godley, L. A., Laucirica, R., Medina, D., Jacks, T., Varmus, H. E. & Donehower, L. A. (1997) Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis. Cell Growth Diff. 8: 829-838.
60. Min mice through different mechanisms. Cancer Res. 63: 1752-1755.
61. Min Mice. Med. Sci. Sports Exerc. 35: 1662-1669.